These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 19093811

  • 1. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M.
    Clin Infect Dis; 2009 Jan 15; 48(2):e16-22. PubMed ID: 19093811
    [Abstract] [Full Text] [Related]

  • 2. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1702-9. PubMed ID: 18419422
    [Abstract] [Full Text] [Related]

  • 3. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP.
    Clin Infect Dis; 2011 Oct 01; 53(7):e91-8. PubMed ID: 21890763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A.
    J Antimicrob Chemother; 2007 Oct 01; 60(4):837-42. PubMed ID: 17684055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
    Delgado Fernández M, García Ordoñez MA, Martos Pérez F, Reguera Iglesias JM, Jiménez Oñate F, Colmenero Castillo JD.
    An Med Interna; 1997 Oct 01; 14(10):506-10. PubMed ID: 9424140
    [Abstract] [Full Text] [Related]

  • 10. [Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].
    Rosenthal E, Delaunay P, Jeandel PY, Haas H, Pomares-Estran C, Marty P.
    Med Mal Infect; 2009 Oct 01; 39(10):741-4. PubMed ID: 19783391
    [Abstract] [Full Text] [Related]

  • 11. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C, Nunes M, Marques M, Henriques S, Rolão N, Campino L.
    Exp Parasitol; 2013 Sep 01; 135(1):36-41. PubMed ID: 23747751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
    de Vallière S, Mary C, Joneberg JE, Rotman S, Bullani R, Greub G, Gillmore JD, Buffet PA, Tarr PE.
    Am J Trop Med Hyg; 2009 Aug 01; 81(2):209-12. PubMed ID: 19635871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J, Spanish HIV-Leishmania Study Group.
    J Antimicrob Chemother; 2004 Mar 01; 53(3):540-3. PubMed ID: 14739148
    [Abstract] [Full Text] [Related]

  • 18. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G, Foglia Manzillo V, Pagano A.
    Parassitologia; 2004 Jun 01; 46(1-2):231-4. PubMed ID: 15305724
    [Abstract] [Full Text] [Related]

  • 19. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.
    d'Ettorre G, Ceccarelli G, Carnevalini M, Forcina G, Zaffiri L, Massetti AP, Mastroianni CM, Vullo V.
    Acta Trop; 2006 Aug 01; 99(1):83-7. PubMed ID: 16962979
    [Abstract] [Full Text] [Related]

  • 20. 'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.
    Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I, Lachaud L.
    HIV Med; 2010 Nov 01; 11(10):670-3. PubMed ID: 20500233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.